IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.40% | 25.32% | 32.45% | 31.72% | 65.34% |
| Total Depreciation and Amortization | -79.00% | -83.41% | -81.20% | 12.61% | -44.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.27% | 94.02% | 79.16% | -7.60% | -871.34% |
| Change in Net Operating Assets | -115.77% | -41.40% | -20.11% | 386.89% | 375.59% |
| Cash from Operations | -3.56% | 49.01% | 51.24% | 43.53% | 57.01% |
| Capital Expenditure | -46.67% | -46.67% | 2.22% | -- | 65.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -132.91% | -132.91% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -132.39% | -130.00% | -87.80% | -13.22% | -42.52% |
| Cash from Investing | -343.37% | -132.27% | -109.01% | -92.13% | -105.35% |
| Total Debt Issued | -- | -- | -- | 129.21% | 129.21% |
| Total Debt Repaid | -1.94% | -640.40% | -549.75% | -502.53% | -612.81% |
| Issuance of Common Stock | 155.06% | 282.64% | 243.09% | 317.41% | 402.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.76% | 103.81% | -1,588.00% | -1,584.00% | -1,584.00% |
| Cash from Financing | 42.33% | -46.11% | -9.43% | -33.46% | -36.57% |
| Foreign Exchange rate Adjustments | -185.45% | -177.27% | 330.00% | -131.67% | 746.00% |
| Miscellaneous Cash Flow Adjustments | 147.62% | 147.62% | 130.00% | -210.00% | -110.00% |
| Net Change in Cash | 274.43% | 54.69% | 85.06% | 95.38% | 86.94% |